[11-19]Pancreatic cancer- biomarkers, research models and individualized therapy

发布者:金雪明发布时间:2019-11-15浏览次数:1551

报 告 人:赵越,博士,普外和肿瘤外科研究组组长

德国科隆大学附属医院 (University Hospital of Cologne)

主 持 人:邓益斌

报告时间:20191119日(周二),9:30

报告地点:苏州大学独墅湖校区药学院三楼2301会议室



个人简介:


  赵越,博士,德国科隆大学附属医院普外和肿瘤外科研究组组长。2013年获慕尼黑大学医学院博士学位,2016年至今,担任科隆大学医学院附属医院普外和肿瘤外科研究组组长,负责科室转化医学研究和拓展。主要从事消化系统肿瘤的转化医学研究、老年肿瘤病人分子靶标鉴定、肿瘤转移及耐药机制、肿瘤干细胞的鉴定和靶向治疗以及骨髓与脂肪来源的间充质干细胞在消化系统肿瘤治疗的临床应用。迄今已在胰腺癌、食管癌、肝癌等研究领域发表转化和基础研究方面SCI论文40余篇,累计影响因子超过230分,相关工作发表于Annal of SurgerySeminar in Cancer BiologyGastroenterologyNatureGutHepatology等杂志。


报告摘要:

First of all, the speaker will give a brief introduction of University of Cologne Medical Faculty including the research focus and education module. For the research interests, the speaker will share some update research highlights and the ongoing research projects on biomarker development for pancreatic cancer, the current in vitro and in vivo models applied in her research team, as well as a few therapeutic targets for potential individualized therapy of pancreatic cancer.